Literature DB >> 18193925

Antidepressants as analgesics.

Gary McCleane1.   

Abstract

Depression is a common accompaniment of pain, particularly when pain is unremitting. The use of a variety of antidepressant medications is associated with pain reduction, an effect that is independent of the mood-enhancing qualities of these drugs. This pain relief is a consequence of a wide variety of actions of antidepressants on the neuroregulatory mechanisms associated with pain perception and transmission. The older tricyclic antidepressants (TCAs) and the newer 'balanced' reuptake inhibitors (such as duloxetine) seem to be more efficacious in terms of providing pain relief than the selective serotonin reuptake inhibitors (SSRIs). Unfortunately, adverse effects are not uncommon during antidepressant use, particularly with TCAs. It is now becoming apparent that TCAs can have an analgesic effect when applied topically and that this effect is produced by peripheral mechanisms rather than systemic uptake. Antidepressants remain a major therapeutic tool in the management of chronic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193925     DOI: 10.2165/00023210-200822020-00005

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  124 in total

1.  Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions.

Authors:  M J Esser; T Chase; G V Allen; J Sawynok
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

2.  Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy.

Authors:  J B Epstein; E L Truelove; H Oien; C Allison; N D Le; M S Epstein
Journal:  Oral Oncol       Date:  2001-12       Impact factor: 5.337

3.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

4.  Peripheral amitriptyline suppresses formalin-induced Fos expression in the rat spinal cord.

Authors:  Caroline E Heughan; Gary V Allen; Teena D Chase; Jana Sawynok
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

5.  Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

Authors:  Smriti Iyengar; Amy A Webster; Susan K Hemrick-Luecke; Jimmy Yu Xu; Rosa Maria A Simmons
Journal:  J Pharmacol Exp Ther       Date:  2004-07-13       Impact factor: 4.030

6.  Molecular mechanisms of the reversal of imipramine-induced sodium channel blockade by alkalinization in human cardiac myocytes.

Authors:  E Bou-Abboud; S Nattel
Journal:  Cardiovasc Res       Date:  1998-05       Impact factor: 10.787

7.  Venlafaxine treatment of fibromyalgia.

Authors:  Kemal Sayar; Gokhan Aksu; Ismail Ak; Mehmet Tosun
Journal:  Ann Pharmacother       Date:  2003-11       Impact factor: 3.154

8.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.

Authors:  K Kieburtz; D Simpson; C Yiannoutsos; M B Max; C D Hall; R J Ellis; C M Marra; R McKendall; E Singer; G J Dal Pan; D B Clifford; T Tucker; B Cohen
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.

Authors:  Anna Haderer; Peter Gerner; Grace Kao; Venkatesh Srinivasa; Ging Kuo Wang
Journal:  Anesth Analg       Date:  2003-06       Impact factor: 5.108

10.  Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats.

Authors:  M Ansuategui; L Naharro; M Feria
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  13 in total

1.  Interrelationship between measures of pain reactions in inflammation and levels of depression in prenatally stressed rat pups.

Authors:  V A Mikhailenko; I P Butkevich; E A Vershinina; P O Semenov
Journal:  Neurosci Behav Physiol       Date:  2009-12-22

2.  Comparison of some behavioral effects of d- and l-methamphetamine in adult male rats.

Authors:  Justin N Siemian; Zhaoxia Xue; Bruce E Blough; Jun-Xu Li
Journal:  Psychopharmacology (Berl)       Date:  2017-04-06       Impact factor: 4.530

Review 3.  Duloxetine: in patients with fibromyalgia.

Authors:  Monique P Curran
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 4.  Psychiatric issues in chronic pain.

Authors:  Michael R Clark
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

5.  Physical and psychosocial functioning following motor vehicle trauma: relationships with chronic pain, posttraumatic stress, and medication use.

Authors:  Joshua D Clapp; Jarod Masci; Shira A Bennett; J Gayle Beck
Journal:  Eur J Pain       Date:  2009-08-11       Impact factor: 3.931

6.  Sensory neuromodulators in functional nausea and vomiting: predictors of response.

Authors:  Amit Patel; Gregory S Sayuk; Vladimir M Kushnir; C Prakash Gyawali
Journal:  Postgrad Med J       Date:  2012-10-30       Impact factor: 2.401

7.  Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice.

Authors:  Pranav Sikka; Sadhna Kaushik; Gyanendra Kumar; Seema Kapoor; V K Bindra; K K Saxena
Journal:  J Pharm Bioallied Sci       Date:  2011-07

8.  Transformation of Lactuca sativa L. with rol C gene results in increased antioxidant potential and enhanced analgesic, anti-inflammatory and antidepressant activities in vivo.

Authors:  Hammad Ismail; Erum Dilshad; Mohammad Tahir Waheed; Moniba Sajid; Waqas Khan Kayani; Bushra Mirza
Journal:  3 Biotech       Date:  2016-10-05       Impact factor: 2.406

9.  Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma.

Authors:  D Andrew Tompkins; J Greg Hobelmann; Peggy Compton
Journal:  Drug Alcohol Depend       Date:  2017-04-01       Impact factor: 4.492

10.  Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites.

Authors:  Tigran Makunts; Marc Axel Wollmer; Ruben Abagyan
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.